Welcome to Flon Labs

FLON Labs specializes in the development and marketing of niche injectable products for the medical community. Learn more about our products.

About Flon

FLON Labs is a new Canadian pharmaceutical company established in 2017, specializing in the supply, manufacture and distribution of niche injectable drug products for all health markets.

At FLON, we align ourselves with quality suppliers of injectable drug products in order to bring products to market in a timely manner and assure they remain available in the longterm for the health community.

We pride ourselves in our ability to anticipate the demands of our consumers by selecting the right products to bring to market.  We continuously strive to meet the ever-increasing demand for niche injectable product in North America.

Finally, FLON invests considerably in research & development, which we believe brings substantial returns to our stakeholders and to the Canadian pharmaceutical industry.

Latest News

  • October 17, 2017
    Par Pharmaceutical Announces First FDA Approval of Vasostrict ®

    >> Learn More
  • October 17, 2017
    Par Pharmaceutical Announces First FDA Approval of Vasostrict ®

    >> Learn More
  • October 17, 2017
    Par Pharmaceutical Announces First FDA Approval of Vasostrict ®

    >> Learn More
  • October 17, 2017
    Par Pharmaceutical Announces First FDA Approval of Vasostrict ®

    >> Learn More